TABLE 4.
ELISA positivity for anti-R-HSP60 and anti-R-OMP2 IgG antibodies in sera of CHD patients and healthy controls
| Subject category | No. positive/total (% positive)a
|
|
|---|---|---|
| Anti-R-HSP60 | Anti-R-OMP2 | |
| Control | 0/100 (0) | 27/100 (27.0) |
| CHD | 217/219 (99.1)* | 156/219 (71.2)* |
| UA | 178/179 (99.5)* | 129/179 (72.0)* |
| AMI | 39/40 (97.5)* | 27/40 (67.5)* |
a
For positivity definition, see Materials and Methods. *, statistically significant difference (P < 0.05 by two-tailed χ2 test) between CHD patients (pooled or individual UA and AMI data) and controls.